주메뉴 바로가기 본문 바로가기

Medical Doctors

Here are the specialists working in GC Labs.

Jooryung Huh

Head Director

M.D., Ph.D.

 

  • Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma
    2023Human PathologyJooryung Huh
  • Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma
    2021Sci RepJooryung Huh
  • A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels
    2021Br J HaematolJooryung Huh
  • Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis
    2021Blood AdvJooryung Huh
  • The limited role of comprehensive staging work-up in ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALToma) with excellent prognosis.
    2021Br J HaematolJooryung Huh
  • Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution.
    2021J Pathol Transl MedJooryung Huh
  • Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.
    2021Cancer Res TreatJooryung Huh
  • Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.
    2021OncoimmunologyJooryung Huh
  • Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.
    2021Blood AdvJooryung Huh
  • Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
    2020Sci RepJooryung Huh
  • Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma.
    2020Front OncolJooryung Huh
  • Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma
    2020Leuk LymphomaJooryung Huh
  • JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma.
    2020Ann Lab MedJooryung Huh
  • Breast implant-associated anaplastic large cell lymphoma: the first South Korean case.
    2020J Pathol Transl MedJooryung Huh
  • A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL
    2020Blood AdvJooryung Huh
  • Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities.
    2020Mod PatholJooryung Huh
  • Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents.
    2020Mol Cancer ResJooryung Huh
  • XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.
    2020J Hematol OncolJooryung Huh
  • Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
    2019BMC CancerJooryung Huh
  • Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma.
    2019Blood ResJooryung Huh
  • Follicular lymphoma with prominent Dutcher body formation after liver transplantation
    2019Blood ResJooryung Huh
  • Endoscopic features and clinical outcomes of colorectal mucosa-associated lymphoid tissue lymphoma.
    2018Gastrointest EndoscJooryung Huh